Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Regulatory Status and Safety Takeaway FDA Status: IGF-1 LR3 is not approved by the FDA for human therapeutic use and is highly restricted
Expected timelines for results Unlike some fast-acting peptides , epitalon's effects on cellular aging manifest gradually
The samples were centrifuged at 15,000 g at 4C, 30 min, and the lower phenolic phase was transferred to a fresh tube
4 weeks 1 vial 28 doses needed
Results showed 87.5% (14 of 16) experienced pain relief, with 91.6% responding to BPC-157 alone without additional treatments
US$ 25.27
US$ 29.79
US$ 20.13
US$ 29.22
US$ 21.72
